Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medulloblastoma | 38 | 2022 | 721 | 3.930 |
Why?
|
Cerebellar Neoplasms | 27 | 2022 | 603 | 2.720 |
Why?
|
Karyotyping | 5 | 2022 | 1266 | 1.430 |
Why?
|
DNA Copy Number Variations | 7 | 2022 | 1894 | 0.810 |
Why?
|
Hedgehog Proteins | 12 | 2014 | 776 | 0.790 |
Why?
|
In Situ Hybridization, Fluorescence | 7 | 2022 | 2648 | 0.760 |
Why?
|
Brain Neoplasms | 16 | 2022 | 8805 | 0.760 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2021 | 1514 | 0.740 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2021 | 209 | 0.730 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2021 | 624 | 0.620 |
Why?
|
Ependymoma | 3 | 2019 | 326 | 0.590 |
Why?
|
Pinealoma | 3 | 2020 | 56 | 0.490 |
Why?
|
Cytogenetic Analysis | 3 | 2022 | 306 | 0.370 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2013 | 1137 | 0.350 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2012 | 671 | 0.350 |
Why?
|
Lysine | 2 | 2012 | 1029 | 0.350 |
Why?
|
Cytogenetics | 5 | 2022 | 213 | 0.310 |
Why?
|
High-Throughput Nucleotide Sequencing | 7 | 2022 | 3689 | 0.300 |
Why?
|
Alternative Splicing | 1 | 2012 | 1126 | 0.290 |
Why?
|
Epigenesis, Genetic | 5 | 2014 | 3428 | 0.290 |
Why?
|
Neoplasms | 7 | 2022 | 20528 | 0.290 |
Why?
|
Neoplasm Metastasis | 8 | 2020 | 5074 | 0.270 |
Why?
|
Chromosome Aberrations | 5 | 2022 | 1808 | 0.270 |
Why?
|
Proto-Oncogene Proteins | 5 | 2019 | 4647 | 0.270 |
Why?
|
Pleural Neoplasms | 2 | 2021 | 619 | 0.270 |
Why?
|
Cerebellum | 6 | 2013 | 1479 | 0.260 |
Why?
|
Ether-A-Go-Go Potassium Channels | 2 | 2015 | 73 | 0.260 |
Why?
|
Genome, Human | 7 | 2022 | 4471 | 0.240 |
Why?
|
Genomics | 10 | 2022 | 5342 | 0.230 |
Why?
|
Homeodomain Proteins | 3 | 2018 | 2442 | 0.230 |
Why?
|
Genetic Testing | 5 | 2022 | 3350 | 0.230 |
Why?
|
DNA-Binding Proteins | 5 | 2020 | 9730 | 0.220 |
Why?
|
MicroRNAs | 6 | 2015 | 3637 | 0.220 |
Why?
|
Gene Expression Profiling | 11 | 2021 | 9504 | 0.210 |
Why?
|
Purine-Nucleoside Phosphorylase | 1 | 2021 | 24 | 0.210 |
Why?
|
Glioblastoma | 3 | 2015 | 3346 | 0.210 |
Why?
|
Sex Chromosome Disorders of Sex Development | 1 | 2020 | 5 | 0.200 |
Why?
|
Genetic Variation | 3 | 2022 | 6664 | 0.200 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2021 | 728 | 0.200 |
Why?
|
Wnt Proteins | 3 | 2014 | 725 | 0.190 |
Why?
|
Signal Transduction | 12 | 2017 | 23729 | 0.190 |
Why?
|
Philadelphia Chromosome | 1 | 2020 | 103 | 0.190 |
Why?
|
Oncogene Proteins, Fusion | 5 | 2020 | 1594 | 0.190 |
Why?
|
Meningeal Neoplasms | 2 | 2022 | 1216 | 0.190 |
Why?
|
Solitary Fibrous Tumor, Pleural | 1 | 2019 | 26 | 0.190 |
Why?
|
Adenoma, Pleomorphic | 1 | 2020 | 75 | 0.180 |
Why?
|
Pineal Gland | 2 | 2017 | 166 | 0.180 |
Why?
|
Microarray Analysis | 4 | 2019 | 778 | 0.180 |
Why?
|
Genes, Tumor Suppressor | 3 | 2013 | 1092 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-myc | 4 | 2022 | 987 | 0.180 |
Why?
|
Sweat Gland Neoplasms | 1 | 2020 | 109 | 0.170 |
Why?
|
E1A-Associated p300 Protein | 1 | 2019 | 127 | 0.170 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2019 | 2985 | 0.170 |
Why?
|
Supratentorial Neoplasms | 1 | 2019 | 160 | 0.170 |
Why?
|
Aneuploidy | 1 | 2021 | 479 | 0.170 |
Why?
|
Transcription Factor RelA | 1 | 2019 | 291 | 0.170 |
Why?
|
Humans | 70 | 2022 | 715777 | 0.170 |
Why?
|
Neuroectodermal Tumors, Primitive | 1 | 2019 | 140 | 0.160 |
Why?
|
Lipoma | 1 | 2020 | 332 | 0.160 |
Why?
|
Infratentorial Neoplasms | 1 | 2018 | 100 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2020 | 380 | 0.160 |
Why?
|
Liposarcoma | 1 | 2020 | 316 | 0.160 |
Why?
|
Lung Neoplasms | 1 | 2021 | 12539 | 0.160 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 258 | 0.150 |
Why?
|
Infertility, Male | 1 | 2020 | 407 | 0.150 |
Why?
|
Genome | 3 | 2021 | 1754 | 0.150 |
Why?
|
CpG Islands | 4 | 2014 | 1171 | 0.150 |
Why?
|
Loss of Heterozygosity | 1 | 2019 | 678 | 0.150 |
Why?
|
Frizzled Receptors | 1 | 2016 | 84 | 0.150 |
Why?
|
Gene Fusion | 1 | 2019 | 371 | 0.150 |
Why?
|
Mitogens | 1 | 2016 | 252 | 0.150 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2016 | 51 | 0.150 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2022 | 8896 | 0.140 |
Why?
|
Thioridazine | 1 | 2015 | 35 | 0.140 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2019 | 311 | 0.140 |
Why?
|
In Situ Hybridization | 1 | 2020 | 1984 | 0.140 |
Why?
|
Genetic Markers | 2 | 2020 | 2688 | 0.140 |
Why?
|
Gene Rearrangement | 1 | 2021 | 1202 | 0.140 |
Why?
|
Retinoblastoma | 1 | 2018 | 315 | 0.140 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2016 | 2465 | 0.140 |
Why?
|
Kv1.1 Potassium Channel | 2 | 2012 | 37 | 0.140 |
Why?
|
Laboratories | 1 | 2019 | 439 | 0.140 |
Why?
|
Cell Proliferation | 14 | 2017 | 10620 | 0.140 |
Why?
|
Repressor Proteins | 3 | 2019 | 3063 | 0.140 |
Why?
|
Carcinoma, Large Cell | 1 | 2015 | 113 | 0.140 |
Why?
|
Lysosomes | 1 | 2020 | 894 | 0.130 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2016 | 731 | 0.130 |
Why?
|
Transcription Factors | 5 | 2022 | 11953 | 0.130 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 641 | 0.130 |
Why?
|
Cluster Analysis | 4 | 2020 | 2758 | 0.130 |
Why?
|
Mutation | 12 | 2019 | 29291 | 0.130 |
Why?
|
Nuclear Proteins | 4 | 2014 | 5947 | 0.130 |
Why?
|
Nerve Tissue Proteins | 4 | 2016 | 4561 | 0.130 |
Why?
|
Germ-Line Mutation | 2 | 2020 | 1727 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 4 | 2019 | 17409 | 0.120 |
Why?
|
DNA Methylation | 6 | 2014 | 4078 | 0.120 |
Why?
|
Elongation Factor 2 Kinase | 1 | 2013 | 11 | 0.120 |
Why?
|
Diagnostic Errors | 1 | 2021 | 1267 | 0.120 |
Why?
|
DNA Mutational Analysis | 5 | 2016 | 4296 | 0.120 |
Why?
|
Forkhead Transcription Factors | 2 | 2019 | 1597 | 0.120 |
Why?
|
Peptide Chain Elongation, Translational | 1 | 2013 | 35 | 0.120 |
Why?
|
Meningioma | 1 | 2022 | 1200 | 0.120 |
Why?
|
Congenital Abnormalities | 1 | 2018 | 696 | 0.120 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2018 | 476 | 0.120 |
Why?
|
MyoD Protein | 1 | 2013 | 160 | 0.120 |
Why?
|
Gene Transfer Techniques | 2 | 2015 | 1282 | 0.120 |
Why?
|
Eye Proteins | 1 | 2016 | 655 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2015 | 8571 | 0.110 |
Why?
|
Clone Cells | 1 | 2016 | 1760 | 0.110 |
Why?
|
NF-kappa B | 2 | 2019 | 2553 | 0.110 |
Why?
|
Mice | 22 | 2022 | 80375 | 0.110 |
Why?
|
Genomic Structural Variation | 1 | 2012 | 62 | 0.110 |
Why?
|
Receptors, Atrial Natriuretic Factor | 1 | 2012 | 56 | 0.110 |
Why?
|
Gene Deletion | 5 | 2021 | 2824 | 0.110 |
Why?
|
Mutagenesis, Insertional | 4 | 2019 | 661 | 0.110 |
Why?
|
Pyrazoles | 3 | 2020 | 1957 | 0.110 |
Why?
|
Soft Tissue Neoplasms | 1 | 2021 | 1356 | 0.110 |
Why?
|
Anilides | 1 | 2014 | 412 | 0.100 |
Why?
|
Mice, Nude | 5 | 2019 | 3801 | 0.100 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 1454 | 0.100 |
Why?
|
Cell Cycle Proteins | 2 | 2014 | 3485 | 0.100 |
Why?
|
Mice, Transgenic | 8 | 2015 | 9849 | 0.100 |
Why?
|
Sequence Analysis, DNA | 3 | 2017 | 4919 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2022 | 1688 | 0.100 |
Why?
|
Comparative Genomic Hybridization | 3 | 2017 | 515 | 0.100 |
Why?
|
Neuroblastoma | 1 | 2018 | 1179 | 0.100 |
Why?
|
Genes, Neoplasm | 1 | 2012 | 386 | 0.100 |
Why?
|
Cell Size | 1 | 2012 | 658 | 0.100 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2012 | 346 | 0.100 |
Why?
|
Pyrimidines | 3 | 2020 | 2930 | 0.100 |
Why?
|
Epigenomics | 2 | 2014 | 806 | 0.100 |
Why?
|
Oncogene Fusion | 2 | 2021 | 110 | 0.100 |
Why?
|
Histone Demethylases | 1 | 2012 | 297 | 0.100 |
Why?
|
Methylation | 1 | 2012 | 1097 | 0.090 |
Why?
|
Histones | 4 | 2014 | 2551 | 0.090 |
Why?
|
Quinolines | 1 | 2014 | 738 | 0.090 |
Why?
|
Gene Regulatory Networks | 3 | 2012 | 1699 | 0.090 |
Why?
|
Neoplasm Proteins | 2 | 2012 | 3741 | 0.090 |
Why?
|
Radiation Tolerance | 1 | 2012 | 509 | 0.090 |
Why?
|
Male | 32 | 2021 | 350324 | 0.090 |
Why?
|
Freezing | 1 | 2009 | 297 | 0.090 |
Why?
|
Prenatal Diagnosis | 1 | 2016 | 1179 | 0.090 |
Why?
|
Telomerase | 1 | 2013 | 736 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 1370 | 0.090 |
Why?
|
Female | 29 | 2021 | 377204 | 0.090 |
Why?
|
Neoplasms, Second Primary | 1 | 2016 | 1010 | 0.090 |
Why?
|
Sciuridae | 1 | 2008 | 75 | 0.090 |
Why?
|
Cell Line, Tumor | 9 | 2015 | 16736 | 0.090 |
Why?
|
Hibernation | 1 | 2008 | 47 | 0.090 |
Why?
|
Adult | 19 | 2022 | 212266 | 0.090 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2014 | 831 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2020 | 2947 | 0.080 |
Why?
|
Blotting, Western | 5 | 2017 | 5379 | 0.080 |
Why?
|
Animals | 24 | 2022 | 169420 | 0.080 |
Why?
|
Fetus | 2 | 2013 | 1853 | 0.080 |
Why?
|
Child | 15 | 2019 | 74468 | 0.080 |
Why?
|
Prognosis | 10 | 2022 | 29005 | 0.080 |
Why?
|
Transforming Growth Factor beta | 2 | 2012 | 1974 | 0.080 |
Why?
|
Disease Models, Animal | 6 | 2020 | 18199 | 0.080 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2015 | 1743 | 0.080 |
Why?
|
Trans-Activators | 1 | 2017 | 3047 | 0.080 |
Why?
|
Software | 1 | 2021 | 4396 | 0.080 |
Why?
|
DNA Transposable Elements | 3 | 2019 | 757 | 0.080 |
Why?
|
Mitosis | 1 | 2012 | 1248 | 0.080 |
Why?
|
Cell Adhesion | 1 | 2014 | 3265 | 0.080 |
Why?
|
Genome-Wide Association Study | 2 | 2016 | 11940 | 0.070 |
Why?
|
Receptors, CXCR4 | 1 | 2011 | 735 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2015 | 4040 | 0.070 |
Why?
|
Evolution, Molecular | 1 | 2015 | 1938 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2019 | 2225 | 0.070 |
Why?
|
Aged | 10 | 2021 | 162448 | 0.070 |
Why?
|
Cadherins | 1 | 2011 | 913 | 0.070 |
Why?
|
Proteins | 2 | 2019 | 6070 | 0.070 |
Why?
|
Genetics, Medical | 2 | 2019 | 324 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2015 | 3633 | 0.070 |
Why?
|
Single-Cell Analysis | 1 | 2016 | 2129 | 0.070 |
Why?
|
Gene Silencing | 4 | 2014 | 1606 | 0.070 |
Why?
|
Computational Biology | 3 | 2015 | 3571 | 0.070 |
Why?
|
Molecular Targeted Therapy | 2 | 2015 | 2824 | 0.070 |
Why?
|
Promoter Regions, Genetic | 2 | 2013 | 6009 | 0.070 |
Why?
|
Young Adult | 8 | 2021 | 56226 | 0.070 |
Why?
|
Glioma | 1 | 2019 | 3302 | 0.060 |
Why?
|
Caenorhabditis elegans | 1 | 2013 | 1410 | 0.060 |
Why?
|
Cell Movement | 5 | 2015 | 5397 | 0.060 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 2 | 2015 | 181 | 0.060 |
Why?
|
Neoplastic Stem Cells | 1 | 2012 | 1373 | 0.060 |
Why?
|
Base Sequence | 2 | 2012 | 13179 | 0.060 |
Why?
|
RNA Interference | 2 | 2015 | 2985 | 0.060 |
Why?
|
Drug Delivery Systems | 1 | 2015 | 2210 | 0.060 |
Why?
|
Neural Stem Cells | 3 | 2019 | 894 | 0.060 |
Why?
|
Chromosome Deletion | 2 | 2020 | 1373 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2018 | 3294 | 0.060 |
Why?
|
RNA-Binding Proteins | 1 | 2012 | 1888 | 0.060 |
Why?
|
Child, Preschool | 9 | 2018 | 41198 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3574 | 0.060 |
Why?
|
Cohort Studies | 5 | 2022 | 40029 | 0.060 |
Why?
|
SOX9 Transcription Factor | 1 | 2022 | 152 | 0.050 |
Why?
|
Gene Dosage | 2 | 2017 | 1270 | 0.050 |
Why?
|
Tumor Cells, Cultured | 3 | 2015 | 6484 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2021 | 58323 | 0.050 |
Why?
|
COS Cells | 2 | 2015 | 1201 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2019 | 8047 | 0.050 |
Why?
|
Middle Aged | 11 | 2021 | 214639 | 0.050 |
Why?
|
Gene Amplification | 2 | 2020 | 1078 | 0.050 |
Why?
|
Mice, Inbred BALB C | 3 | 2015 | 6641 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2016 | 5198 | 0.050 |
Why?
|
Adolescent | 10 | 2021 | 85155 | 0.050 |
Why?
|
Sex Chromosome Aberrations | 1 | 2020 | 111 | 0.050 |
Why?
|
Cell Cycle | 3 | 2014 | 2993 | 0.050 |
Why?
|
RNA, Messenger | 2 | 2012 | 13213 | 0.050 |
Why?
|
Apoptosis | 5 | 2016 | 9973 | 0.050 |
Why?
|
Nortriptyline | 1 | 2020 | 83 | 0.050 |
Why?
|
Translocation, Genetic | 2 | 2018 | 1414 | 0.050 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2019 | 42 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2014 | 19537 | 0.050 |
Why?
|
Genes, p53 | 2 | 2012 | 764 | 0.050 |
Why?
|
Piperidines | 2 | 2019 | 1582 | 0.050 |
Why?
|
Chromosomes, Human, Y | 1 | 2020 | 148 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2017 | 15603 | 0.040 |
Why?
|
PTEN Phosphohydrolase | 2 | 2015 | 1161 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 4893 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2021 | 10605 | 0.040 |
Why?
|
Infant | 6 | 2018 | 34569 | 0.040 |
Why?
|
Neurofibromin 2 | 1 | 2019 | 270 | 0.040 |
Why?
|
Mice, SCID | 2 | 2014 | 2787 | 0.040 |
Why?
|
Calcitonin | 1 | 2019 | 352 | 0.040 |
Why?
|
Carbazoles | 1 | 2019 | 238 | 0.040 |
Why?
|
Virulence | 1 | 2022 | 1338 | 0.040 |
Why?
|
Integrases | 1 | 2020 | 548 | 0.040 |
Why?
|
Phenotype | 4 | 2019 | 16311 | 0.040 |
Why?
|
Immunohistochemistry | 3 | 2021 | 11689 | 0.040 |
Why?
|
Mosaicism | 1 | 2020 | 447 | 0.040 |
Why?
|
RNA | 2 | 2020 | 2613 | 0.040 |
Why?
|
Ribonuclease III | 2 | 2009 | 275 | 0.040 |
Why?
|
Retinoblastoma Protein | 1 | 2020 | 698 | 0.040 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2019 | 435 | 0.040 |
Why?
|
Chromosome Banding | 1 | 2016 | 284 | 0.040 |
Why?
|
World Health Organization | 1 | 2022 | 1286 | 0.040 |
Why?
|
Histiocytic Sarcoma | 1 | 2016 | 46 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6722 | 0.040 |
Why?
|
GTPase-Activating Proteins | 1 | 2019 | 492 | 0.030 |
Why?
|
Neoplasm Invasiveness | 2 | 2015 | 3681 | 0.030 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2017 | 493 | 0.030 |
Why?
|
Cell Transdifferentiation | 1 | 2016 | 190 | 0.030 |
Why?
|
Chromosomes | 1 | 2018 | 597 | 0.030 |
Why?
|
Transplantation, Heterologous | 2 | 2014 | 2425 | 0.030 |
Why?
|
Mice, Inbred C57BL | 4 | 2015 | 22665 | 0.030 |
Why?
|
Documentation | 1 | 2021 | 873 | 0.030 |
Why?
|
Guanine Nucleotide Dissociation Inhibitors | 1 | 2014 | 21 | 0.030 |
Why?
|
Transfection | 2 | 2015 | 6089 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2016 | 12305 | 0.030 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2018 | 336 | 0.030 |
Why?
|
Tumor Stem Cell Assay | 1 | 2014 | 122 | 0.030 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2014 | 39 | 0.030 |
Why?
|
Pediatrics | 1 | 2010 | 3552 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 622 | 0.030 |
Why?
|
Rhombencephalon | 1 | 2014 | 80 | 0.030 |
Why?
|
Peptide Elongation Factor 2 | 1 | 2013 | 19 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 13217 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2019 | 1413 | 0.030 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2014 | 308 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2015 | 356 | 0.030 |
Why?
|
Food Deprivation | 1 | 2013 | 128 | 0.030 |
Why?
|
Protein Biosynthesis | 2 | 2012 | 2137 | 0.030 |
Why?
|
HEK293 Cells | 2 | 2012 | 4266 | 0.030 |
Why?
|
Cell Differentiation | 3 | 2017 | 11655 | 0.030 |
Why?
|
Cathepsin B | 1 | 2012 | 88 | 0.030 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2014 | 414 | 0.030 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2012 | 87 | 0.030 |
Why?
|
Genetic Counseling | 1 | 2016 | 578 | 0.030 |
Why?
|
Cell Survival | 2 | 2013 | 6035 | 0.030 |
Why?
|
Smad3 Protein | 1 | 2012 | 191 | 0.030 |
Why?
|
Colony-Forming Units Assay | 1 | 2012 | 369 | 0.030 |
Why?
|
Chromatography, Thin Layer | 1 | 2012 | 238 | 0.030 |
Why?
|
Pteridines | 1 | 2012 | 47 | 0.030 |
Why?
|
Cranial Irradiation | 1 | 2015 | 441 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2014 | 573 | 0.030 |
Why?
|
DNA Restriction Enzymes | 1 | 2012 | 606 | 0.030 |
Why?
|
Electrophoresis, Capillary | 1 | 2012 | 75 | 0.030 |
Why?
|
Sulfites | 1 | 2012 | 95 | 0.030 |
Why?
|
Autophagy | 1 | 2020 | 1314 | 0.030 |
Why?
|
Abortion, Spontaneous | 1 | 2016 | 475 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2014 | 373 | 0.030 |
Why?
|
Intermediate Filament Proteins | 1 | 2012 | 274 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2013 | 691 | 0.030 |
Why?
|
Organ Culture Techniques | 1 | 2014 | 856 | 0.030 |
Why?
|
Gene Duplication | 1 | 2012 | 334 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2016 | 886 | 0.030 |
Why?
|
Genes, myc | 1 | 2012 | 401 | 0.030 |
Why?
|
Adenine | 1 | 2016 | 897 | 0.030 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2012 | 120 | 0.030 |
Why?
|
Meninges | 1 | 2012 | 184 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2012 | 513 | 0.020 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2014 | 526 | 0.020 |
Why?
|
Cytosine | 1 | 2012 | 218 | 0.020 |
Why?
|
Spheroids, Cellular | 1 | 2012 | 332 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2013 | 966 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2014 | 604 | 0.020 |
Why?
|
Luciferases | 1 | 2012 | 750 | 0.020 |
Why?
|
Ranidae | 1 | 2009 | 28 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2012 | 331 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2012 | 936 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2013 | 619 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1801 | 0.020 |
Why?
|
Genotype | 2 | 2015 | 12919 | 0.020 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2015 | 839 | 0.020 |
Why?
|
Cell Death | 1 | 2015 | 1724 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2020 | 4352 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1904 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2013 | 2124 | 0.020 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2012 | 672 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2883 | 0.020 |
Why?
|
Carrier Proteins | 2 | 2012 | 5102 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2720 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2015 | 15059 | 0.020 |
Why?
|
Canada | 1 | 2013 | 1967 | 0.020 |
Why?
|
Proteoglycans | 1 | 2011 | 831 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2017 | 2995 | 0.020 |
Why?
|
Blood-Brain Barrier | 1 | 2014 | 1004 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2014 | 2840 | 0.020 |
Why?
|
Drosophila | 1 | 2015 | 1462 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2647 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2012 | 1703 | 0.020 |
Why?
|
Adenosine | 1 | 2012 | 819 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2014 | 1659 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2014 | 19910 | 0.020 |
Why?
|
Europe | 1 | 2013 | 3343 | 0.020 |
Why?
|
Remission Induction | 1 | 2012 | 2394 | 0.020 |
Why?
|
HeLa Cells | 1 | 2013 | 3213 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3551 | 0.020 |
Why?
|
Chromatin | 1 | 2017 | 2686 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6736 | 0.020 |
Why?
|
Disease Progression | 2 | 2013 | 13215 | 0.020 |
Why?
|
Probability | 1 | 2011 | 2487 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2012 | 3818 | 0.020 |
Why?
|
Embryonic Stem Cells | 1 | 2014 | 1373 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2022 | 72443 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2012 | 1571 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2009 | 1550 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 13626 | 0.020 |
Why?
|
Age of Onset | 1 | 2011 | 3316 | 0.020 |
Why?
|
Models, Neurological | 1 | 2012 | 1781 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2008 | 2399 | 0.020 |
Why?
|
Spinal Cord | 1 | 2012 | 1808 | 0.020 |
Why?
|
Down-Regulation | 1 | 2011 | 3066 | 0.010 |
Why?
|
Muscle, Skeletal | 2 | 2009 | 4931 | 0.010 |
Why?
|
Organ Specificity | 1 | 2008 | 2034 | 0.010 |
Why?
|
Cell Lineage | 1 | 2012 | 2594 | 0.010 |
Why?
|
Up-Regulation | 1 | 2012 | 4312 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8890 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2012 | 2918 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 11201 | 0.010 |
Why?
|
Regression Analysis | 1 | 2011 | 6495 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 6093 | 0.010 |
Why?
|
Phosphorylation | 1 | 2012 | 8658 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2012 | 3898 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2009 | 2008 | 0.010 |
Why?
|
Survival Analysis | 1 | 2012 | 10499 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12456 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 18591 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15199 | 0.010 |
Why?
|
Cell Line | 1 | 2012 | 16576 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5412 | 0.010 |
Why?
|
Survival Rate | 1 | 2012 | 13206 | 0.010 |
Why?
|
Risk Factors | 2 | 2014 | 70866 | 0.010 |
Why?
|
Logistic Models | 1 | 2011 | 13618 | 0.010 |
Why?
|
Myocardium | 1 | 2008 | 4909 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2012 | 21797 | 0.010 |
Why?
|
Liver | 1 | 2009 | 7594 | 0.010 |
Why?
|
Neurons | 1 | 2012 | 9375 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 62004 | 0.010 |
Why?
|
Kidney | 1 | 2008 | 6881 | 0.010 |
Why?
|
Risk Assessment | 1 | 2014 | 23464 | 0.010 |
Why?
|
Time Factors | 1 | 2013 | 40875 | 0.010 |
Why?
|
Prospective Studies | 1 | 2015 | 51315 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 34430 | 0.010 |
Why?
|
United States | 1 | 2013 | 67905 | 0.000 |
Why?
|